Applied therapeutics reports fourth quarter and year-end 2021 financial results

Progress in three phase 3 trials in areas of high unmet clinical need, with multiple clinical and regulatory milestones expected in 2022 progress in three phase 3 trials in areas of high unmet clinical need, with multiple clinical and regulatory milestones expected in 2022
APLT Ratings Summary
APLT Quant Ranking